Fecal microbiota, fecal metabolome, and colorectal cancer interrelations

PLoS ONE

Volumn 11, Issue 3, 2016, Pages

  Sinha, Rashmi ^a   Ahn, Jiyoung ^b   Sampson, Joshua N ^a   Shi, Jianxin ^a   Yu, Guoqin ^a   Xiong, Xiaoqin ^c   Hayes, Richard B ^b   Goedert, James J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INFORMATION MANAGEMENT SERVICES INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; CASE CONTROL STUDY; COLORECTAL TUMOR; FALSE POSITIVE RESULT; FECES; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; INFLAMMATION; INNATE IMMUNITY; INTESTINE; INTESTINE FLORA; MALE; META ANALYSIS; METABOLISM; METABOLOME; MICROBIOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS;

AGED; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FALSE POSITIVE REACTIONS; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNITY, INNATE; INFLAMMATION; INTESTINES; MALE; METABOLOME; MIDDLE AGED; MULTIVARIATE ANALYSIS;

EID: 84991358759     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0152126     Document Type: Article

References (47)

1. Le Chatelier E, Nielsen T, Qin J, Prifti E, Hildebrand F, Falony G, et al. Richness of human gut microbiome correlates with metabolic markers. Nature. 2013; 500(7464):541–6. Epub 2013/08/30. doi: 10. 1038/nature12506 PMID: 23985870.
2. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, et al. A core gut microbiome in obese and lean twins. Nature. 2009; 457(7228):480–4. Epub 2008/12/02. doi: 10.1038/ nature07540 PMID: 19043404; PubMed Central PMCID: PMC2677729.
3. Smith MI, Yatsunenko T, Manary MJ, Trehan I, Mkakosya R, Cheng J, et al. Gut Microbiomes of Malawian Twin Pairs Discordant for Kwashiorkor. Science. 2013. Epub 2013/02/01. doi: 10.1126/science. 1229000 PMID: 23363771.
4. McHardy IH, Goudarzi M, Tong M, Ruegger PM, Schwager E, Weger JR, et al. Integrative analysis of the microbiome and metabolome of the human intestinal mucosal surface reveals exquisite inter-relationships. Microbiome. 2013; 1(1):17. doi: 10.1186/2049-2618-1-17 PMID: 24450808; PubMed Central PMCID: PMC3971612.
5. Tjalsma H, Boleij A, Marchesi JR, Dutilh BE. A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects. Nature reviews Microbiology. 2012; 10(8):575–82. Epub 2012/06/26. doi: 10.1038/nrmicro2819 PMID: 22728587.
6. Scanlan PD, Shanahan F, Clune Y, Collins JK, O'Sullivan GC, O'Riordan M, et al. Culture-independent analysis of the gut microbiota in colorectal cancer and polyposis. Environmental microbiology. 2008; 10 (3):789–98. doi: 10.1111/j.1462-2920.2007.01503.x PMID: 18237311.
7. Jobin C. Colorectal cancer: looking for answers in the microbiota. Cancer discovery. 2013; 3(4):384–7. doi: 10.1158/2159-8290.CD-13-0042 PMID: 23580283; PubMed Central PMCID: PMC3625977.
8. Uronis JM, Muhlbauer M, Herfarth HH, Rubinas TC, Jones GS, Jobin C. Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility. PloS one. 2009; 4(6):e6026. doi: 10.1371/journal.pone.0006026 PMID: 19551144; PubMed Central PMCID: PMC2696084.
9. Arthur JC, Perez-Chanona E, Muhlbauer M, Tomkovich S, Uronis JM, Fan TJ, et al. Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota. Science. 2012. Epub 2012/08/21. doi: 10.1126/ science.1224820 PMID: 22903521.
10. Allen-Vercoe E, Jobin C. Fusobacterium and Enterobacteriaceae: important players for CRC? Immunology letters. 2014; 162(2 Pt A):54–61. doi: 10.1016/j.imlet.2014.05.014 PMID: 24972311; PubMed Central PMCID: PMC4259803.
11. Zeller G, Tap J, Voigt AY, Sunagawa S, Kultima JR, Costea PI, et al. Potential of fecal microbiota for early-stage detection of colorectal cancer. Molecular systems biology. 2014; 10:766. Epub 2014/11/30. doi: 10.15252/msb.20145645 PMID: 25432777.
12. Turnbaugh PJ, Quince C, Faith JJ, McHardy AC, Yatsunenko T, Niazi F, et al. Organismal, genetic, and transcriptional variation in the deeply sequenced gut microbiomes of identical twins. Proceedings of the National Academy of Sciences of the United States of America. 2010; 107(16):7503–8. Epub 2010/04/07. doi: 10.1073/pnas.1002355107 PMID: 20363958; PubMed Central PMCID: PMC2867707.
13. Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Science translational medicine. 2009; 1(6):6ra14. Epub 2010/04/07. doi: 10.1126/scitranslmed.3000322 PMID: 20368178; PubMed Central PMCID: PMC2894525.
14. Feng Q, Liang S, Jia H, Stadlmayr A, Tang L, Lan Z, et al. Gut microbiome development along the colorectal adenoma-carcinoma sequence. Nature communications. 2015; 6:6528. doi: 10.1038/ ncomms7528 PMID: 25758642.
15. Yen S, McDonald JA, Schroeter K, Oliphant K, Sokolenko S, Blondeel EJ, et al. Metabolomic analysis of human fecal microbiota: a comparison of feces-derived communities and defined mixed communities. Journal of proteome research. 2015; 14(3):1472–82. doi: 10.1021/pr5011247 PMID: 25670064.
16. Ahn J, Sinha R, Pei Z, Dominianni C, Wu J, Shi J, et al. Human gut microbiome and risk for colorectal cancer. Journal of the National Cancer Institute. 2013; 105(24):1907–11. Epub 2013/12/10. doi: 10. 1093/jnci/djt300 PMID: 24316595; PubMed Central PMCID: PMC3866154.
17. Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, et al. Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014; 35(9):2089–96. Epub 2014/07/20. doi: 10.1093/carcin/bgu131 PMID: 25037050; PubMed Central PMCID: PMC4146421.
18. Schiffman MH, Andrews AW, Van Tassell RL, Smith L, Daniel J, Robinson A, et al. Case-control study of colorectal cancer and fecal mutagenicity. Cancer research. 1989; 49(12):3420–4. Epub 1989/06/15. PMID: 2655896.
19. Schiffman MH, Van Tassell RL, Robinson A, Smith L, Daniel J, Hoover RN, et al. Case-control study of colorectal cancer and fecapentaene excretion. Cancer research. 1989; 49(5):1322–6. Epub 1989/03/ 01. PMID: 2917361.
20. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, et al. QIIME allows analysis of high-throughput community sequencing data. Nature methods. 2010; 7(5):335–6. Epub 2010/04/13. doi: 10.1038/nmeth.f.303 PMID: 20383131; PubMed Central PMCID: PMC3156573.
21. Evans AM, DeHaven CD, Barrett T, Mitchell M, Milgram E. Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. Analytical chemistry. 2009; 81(16):6656–67. doi: 10.1021/ac901536h PMID: 19624122.
22. Sha W, da Costa KA, Fischer LM, Milburn MV, Lawton KA, Berger A, et al. Metabolomic profiling can predict which humans will develop liver dysfunction when deprived of dietary choline. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 2010; 24(8):2962–75. doi: 10.1096/fj.09-154054 PMID: 20371621; PubMed Central PMCID: PMC2909293.
23. Toprak Ulger N, Bozan T, Birkan Y, Isbir S, Soyletir G. Butyricimonas virosa: the first clinical case of bacteraemia. New Microbes New Infections. 2015; 4:7–8. doi: 10.1016/j.nmni.2014.12.004 PMID: 25830028
24. Lau SK, McNabb A, Woo GK, Hoang L, Fung AM, Chung LM, et al. Catabacter hongkongensis gen. nov., sp. nov., isolated from blood cultures of patients from Hong Kong and Canada. Journal of clinical microbiology. 2007; 45(2):395–401. doi: 10.1128/JCM.01831-06 PMID: 17122022; PubMed Central PMCID: PMC1829005.
25. Codony F, Adrados B, Perez LM, Fittipaldi M, Morato J. Detection of Catabacter hongkongensis in polluted European water samples. Journal of Zhejiang University Science B. 2009; 10(12):867–9. doi: 10. 1631/jzus.B0920218 PMID: 19946949; PubMed Central PMCID: PMC2789520.
26. Jahn M, Baynes JW, Spiteller G. The reaction of hyaluronic acid and its monomers, glucuronic acid and N-acetylglucosamine, with reactive oxygen species. Carbohydrate research. 1999; 321(3–4):228–34. PMID: 10614067.
27. Ellis JK, Athersuch TJ, Thomas LD, Teichert F, Perez-Trujillo M, Svendsen C, et al. Metabolic profiling detects early effects of environmental and lifestyle exposure to cadmium in a human population. BMC medicine. 2012; 10:61. doi: 10.1186/1741-7015-10-61 PMID: 22713677; PubMed Central PMCID: PMC3391181.
28. Donadio S, Sosio M, Lancini G. Impact of the first Streptomyces genome sequence on the discovery and production of bioactive substances. Applied microbiology and biotechnology. 2002; 60(4):377–80. doi: 10.1007/s00253-002-1143-0 PMID: 12466876.
29. Donia MS, Fischbach MA. HUMAN MICROBIOTA. Small molecules from the human microbiota. Science. 2015; 349(6246):1254766. doi: 10.1126/science.1254766 PMID: 26206939.
30. Linardic CM, Hannun YA. Identification of a distinct pool of sphingomyelin involved in the sphingomyelin cycle. The Journal of biological chemistry. 1994; 269(38):23530–7. PMID: 8089120.
31. Kostic AD, Gevers D, Pedamallu CS, Michaud M, Duke F, Earl AM, et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome research. 2012; 22(2):292–8. Epub 2011/10/20. doi: 10.1101/gr.126573.111 PMID: 22009990; PubMed Central PMCID: PMC3266036.
32. Castellarin M, Warren RL, Freeman JD, Dreolini L, Krzywinski M, Strauss J, et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome research. 2012; 22(2):299–306. Epub 2011/10/20. doi: 10.1101/gr.126516.111 PMID: 22009989; PubMed Central PMCID: PMC3266037.
33. Storey A, Rogers JS, McArdle F, Jackson MJ, Rhodes LE. Conjugated linoleic acids modulate UVR-induced IL-8 and PGE2 in human skin cells: potential of CLA isomers in nutritional photoprotection. Carcinogenesis. 2007; 28(6):1329–33. Epub 2007/03/29. doi: 10.1093/carcin/bgm065 PMID: 17389616.
34. Zulet MA, Marti A, Parra MD, Martinez JA. Inflammation and conjugated linoleic acid: mechanisms of action and implications for human health. Journal of physiology and biochemistry. 2005; 61(3):483–94. Epub 2006/01/31. PMID: 16440602.
35. Belury MA. Conjugated dienoic linoleate: a polyunsaturated fatty acid with unique chemoprotective properties. Nutrition reviews. 1995; 53(4 Pt 1):83–9. Epub 1995/04/01. PMID: 7624062.
36. Huang CB, George B, Ebersole JL. Antimicrobial activity of n-6, n-7 and n-9 fatty acids and their esters for oral microorganisms. Archives of oral biology. 2010; 55(8):555–60. doi: 10.1016/j.archoralbio.2010. 05.009 PMID: 20541177; PubMed Central PMCID: PMC2902640.
37. Gholami Z, Khosravi-Darani K. An overview of conjugated linoleic acid: microbial production and application. Mini reviews in medicinal chemistry. 2014; 14(9):734–46. PMID: 25138090.
38. Ottesen AR, Gonzalez Pena A, White JR, Pettengill JB, Li C, Allard S, et al. Baseline survey of the anatomical microbial ecology of an important food plant: Solanum lycopersicum (tomato). BMC microbiology. 2013; 13:114. doi: 10.1186/1471-2180-13-114 PMID: 23705801; PubMed Central PMCID: PMC3680157.
39. Rastogi G, Sbodio A, Tech JJ, Suslow TV, Coaker GL, Leveau JH. Leaf microbiota in an agroecosystem: spatiotemporal variation in bacterial community composition on field-grown lettuce. The ISME journal. 2012; 6(10):1812–22. doi: 10.1038/ismej.2012.32 PMID: 22534606; PubMed Central PMCID: PMC3446804.
40. Cociancich S, Pesic A, Petras D, Uhlmann S, Kretz J, Schubert V, et al. The gyrase inhibitor albicidin consists of p-aminobenzoic acids and cyanoalanine. Nature chemical biology. 2015; 11(3):195–7. doi: 10.1038/nchembio.1734 PMID: 25599532.
41. Vanden Bussche J, Marzorati M, Laukens D, Vanhaecke L. Validated High Resolution Mass Spectrometry-Based Approach for Metabolomic Fingerprinting of the Human Gut Phenotype. Analytical chemistry. 2015; 87(21):10927–34. doi: 10.1021/acs.analchem.5b02688 PMID: 26451617.
42. Xu W, Chen D, Wang N, Zhang T, Zhou R, Huan T, et al. Development of high-performance chemical isotope labeling LC-MS for profiling the human fecal metabolome. Analytical chemistry. 2015; 87 (2):829–36. doi: 10.1021/ac503619q PMID: 25486321.
43. Dejea CM, Wick EC, Hechenbleikner EM, White JR, Mark Welch JL, Rossetti BJ, et al. Microbiota organization is a distinct feature of proximal colorectal cancers. Proceedings of the National Academy of Sciences of the United States of America. 2014; 111(51):18321–6. doi: 10.1073/pnas.1406199111 PMID: 25489084; PubMed Central PMCID: PMC4280621.
44. Brown EM, Sadarangani M, Finlay BB. The role of the immune system in governing host-microbe interactions in the intestine. Nature immunology. 2013; 14(7):660–7. doi: 10.1038/ni.2611 PMID: 23778793.
45. Flores R, Shi J, Gail MH, Gajer P, Ravel J, Goedert JJ. Association of fecal microbial diversity and taxonomy with selected enzymatic functions. PloS one. 2012; 7(6):e39745. Epub 2012/07/05. doi: 10. 1371/journal.pone.0039745 PMID: 22761886; PubMed Central PMCID: PMC3386201.
46. Arpaia N, Campbell C, Fan X, Dikiy S, van der Veeken J, deRoos P, et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature. 2013; 504(7480):451–5. doi: 10.1038/nature12726 PMID: 24226773; PubMed Central PMCID: PMC3869884.
47. Mai V, Morris JG Jr. Need for prospective cohort studies to establish human gut microbiome contributions to disease risk. Journal of the National Cancer Institute. 2013; 105(24):1850–1. doi: 10.1093/jnci/ djt349 PMID: 24316594.